– Broad label inclusive of all ages and disease severities – – Launch to be initiated in Germany – WARREN, N.J., June 24, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Sephience™ (sepiapterin) was granted marketing authorization by the European Commission...
Read More Details
Finally We wish PressBee provided you with enough information of ( Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU) )
Also on site :
- Amazon Has an Iconic $100 LEGO Fountain Garden Set on Sale for Just $64, and Shoppers Say It’s 'Easy to Put Together'
- Iconic '90s Actress, 55, Flaunts ‘Agelessly Sexy Beauty’ in Itty-Bitty String Bikini
- DNC Chair Ken Martin condemns ‘despicable’ mega-bill, calls Tillis top target in interview